AZGP1 and prostate carcinoma: Recent studies [23,24,25,26,27,28,29] have revealed that AZGP1 could suppress the malignant phenotype in several cancers, including GC, colorectal cancer, prostate cancer, hepatocellular carcinoma, and so on.